Chemo drugs
Terms
undefined, object
copy deck
- Cyclophosphamide
- Alkylating agents
- Ifosamide
- Alkylating agents
- Mechlorethamine
- Alkylating agents
- Melphalan
- Alkylating agents
- Chlorambucil
- Alkylating agents
- Busulfan
- Alkylating agents
- Carmustine
- Alkylating agents
- Lomustine
- Alkylating agents
- Streptozocin
- Alkylating agents
- Thiopenta
- Alkylating agents
- Dacarbazine
- Alkylating agents
- Temozolomide
- Alkylating agents
- Procarbazine
- Alkylating agents
- Carboplatin
- DNA binding agents
- Cisplatin
- DNA binding agents
- Oxaliplatin
- DNA binding agents
- Cytarabine
- Antimetabolite
- Fludarabine
- Antimetabolite
- Gemcitabine
- Antimetabolite
- Pentostatin
- Antimetabolite
- Cladribine
- Antimetabolite
- 6-Mercaptopurine
- Antimetabolite
- 6-Thioguanine
- Antimetabolite
- Methotrexate
- Antimetabolite
- Pemetrexed
- Antimetabolite
- 5-Flurouracil
- Antimetabolite
- Capecitabine
- Antimetabolite
- Doxorubicin
- Antitumor Antibiotics [and Topo II inhib]
- Daunorubicin
- Antitumor Antibiotics [and Topo II inhib]
- Epirubicin
- Antitumor Antibiotics
- Idarubicin
- Antitumor Antibiotics
- Mitoxantrone
- Antitumor Antibiotics
- Actinomycin D
- Antitumor Antibiotics
- Bleomycin
- Antitumor Antibiotics
- Irinotecan
- Topoisomerase I inhib
- Topotecan
- Topoisomerase I inhib
- Etoposide
- Topoisomerase II inhib
- Teniposide
- Topoisomerase II inhib
- Vincristine
- Mitotic inhibitor
- Vinblastine
- Mitotic inhibitor
- Vinorelbine
- Mitotic inhibitor
- Paclitaxel
- Mitotic inhibitor
- Docetaxel
- Mitotic inhibitor
- Ixabepilone
- Mitotic inhibitor
- Dasatanib
- Signal Transduction Inhibitor
- Erlotnib
- Signal Transduction Inhibitor
- Imatinib
- Signal Transduction Inhibitor
- Lapatinib
- Signal Transduction Inhibitor
- Sorafenib
- Signal Transduction Inhibitor
- Sunitinib
- Signal Transduction Inhibitor
- Temsirolimus
- Signal Transduction Inhibitor
- Arsenic toxide
- Differentiating agents [Enzymes and misc drugs]
- Tretinoin
- Differentiating agents [Enzymes and misc drugs]
- L-Asparaginase
- Enzymes [Enzymes and misc drugs]
- Hydroxyurea
- Ribonucleotide reductase inhibitor [Enzymes and misc drugs]
- Bortezomib
- Proteasome inhibitor [Enzymes and misc drugs]
- Vorinostat
- Histone deacetylase inhibitor [Enzymes and misc drugs]
- Tamoxifen
- Antiestrogen Endocrine Therapies
- Fulvestrant
- Antiestrogen Endocrine Therapies
- Toremifine
- Antiestrogen Endocrine Therapies
- Megestrol
- Misc. hormones Endocrine Therapies
- Aminoglutethimide
- Aromatase inhibitor Endocrine Therapies
- Anastrozole
- Competitive aromatase inhibitor Endocrine Therapies
- Letrozole
- Competitive aromatase inhibitor Endocrine Therapies
- Exemastane
- Irreversible aromatase inhibitor Endocrine Therapies
- Biclutamide
- Androgen receptor antagonist Endocrine Therapies
- Flutamide
- Androgen receptor antagonist Endocrine Therapies
- Leuprolide
- GnRH agonist Endocrine Therapies
- Alpha interferon
- Interferon Biotherapy
- Aldesleukin
- Interleukin Biotherapy
- Denileukin diftitox
- Interleukin Biotherapy
- Alemtuzumab
- Monoclonal antibodies
- Bevacizumab
- Monoclonal antibodies
- Cetuximab
- Monoclonal antibodies
- Panitumumab
- Monoclonal antibodies
- Rituximab
- Monoclonal antibodies
- Trastuzumab
- Monoclonal antibodies
- Gemtuzumab ozogomicin
- Monoclonal antibodies
- Tositumomab
- Monoclonal antibodies
- Erythropoietin
- Hematopoietic Growth Factors
- Darbopoietin alpha
- Hematopoietic Growth Factors
- Filgrastim
- Hematopoietic Growth Factors
- Pegfilgrastim
- Hematopoietic Growth Factors
- Sargramostim
- Hematopoietic Growth Factors
- Oprelvekin
- Hematopoietic Growth Factors